Treatment options for tic disorders

被引:9
|
作者
Rizzo, Renata [1 ]
Gulisano, Mariangela [1 ]
机构
[1] Catania Univ, Dept Clin & Expt Med, Child & Adolescent Psychiat Sect, Via Santa Sofia 78, I-95123 Catania, Italy
关键词
Alpha-2; agonists; antipsychotics; tics; Tourette syndrome; vesicular monoamine transporter-2 inhibitors; PLACEBO-CONTROLLED TRIAL; OPEN-LABEL OLANZAPINE; LA-TOURETTE-SYNDROME; DOUBLE-BLIND; 2ND-GENERATION ANTIPSYCHOTICS; PHARMACOLOGICAL-TREATMENT; CHILDREN; ADOLESCENTS; RISPERIDONE; CLONIDINE;
D O I
10.1080/14737175.2020.1698950
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder, characterized by the presence of multiple motor and, at least one, phonic tics, for more than one year, beginning before 18 years of age; its treatment is often a challenge for the clinician Areas covered: GTS treatment requires a multidisciplinary management to treat each patient's symptom. Although individuals with GTS often have comorbid psychiatric disorders, the focus of this review will only be on the management of tics. Expert opinion: The authors summarized the steps that clinicians should follow treating GTS patient; the impact of the tics on a patients' life should be the first step; different patients could present different levels of tolerance to the symptoms. Second, comorbidities should be considered before starting a treatment for tic. Finally, clinicians must focus the attention of the patient and family, on the length of the treatment and the duration of time after which the effects of the drug will occur. Before the treatment, the potential side effects must be mentioned to the parents, and the choice of treatment must be made in the light of the patient's tolerance to these.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 50 条
  • [31] Tic disorders
    Hebebrand, J
    MONATSSCHRIFT KINDERHEILKUNDE, 2004, 152 (12) : 1313 - 1318
  • [32] Tic disorders
    Leckman, JF
    Peterson, BS
    Pauls, DL
    Cohen, DJ
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 1997, 20 (04) : 839 - +
  • [33] Neurocognitive predictors of treatment response to randomized treatment in adults with tic disorders
    Abramovitch, Amitai
    Hallion, Lauren S.
    Reese, Hannah E.
    Woods, Douglas W.
    Peterson, Alan
    Walkup, John T.
    Piacentini, John
    Scahill, Lawrence
    Deckersbach, Thilo
    Wilhelm, Sabine
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2017, 74 : 9 - 14
  • [34] Tic disorders revisited: introduction of the term "tic spectrum disorders"
    Mueller-Vahl, Kirsten R.
    Sambrani, Tanvi
    Jakubovski, Ewgeni
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2019, 28 (08) : 1129 - 1135
  • [35] Tic disorders revisited: introduction of the term “tic spectrum disorders”
    Kirsten R. Müller-Vahl
    Tanvi Sambrani
    Ewgeni Jakubovski
    European Child & Adolescent Psychiatry, 2019, 28 : 1129 - 1135
  • [36] Female sexual disorders: Treatment options in the pipeline
    Krychman, Michael L.
    Kingsberg, Sheryl A.
    FORMULARY, 2013, 48 (03) : 113 - 115
  • [37] Adjustment disorders -: Nosological state and treatment options
    Jaeger, Markus
    Frasch, Karel
    Becker, Thomas
    PSYCHIATRISCHE PRAXIS, 2008, 35 (05) : 219 - 225
  • [38] Treatment options for the management of pervasive developmental disorders
    Nash, Kathryn
    Carter, K. Jennifer
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2016, 51 (02): : 201 - 210
  • [39] CONGENITAL BLEEDING DISORDERS - RATIONAL TREATMENT OPTIONS
    SEREMETIS, SV
    ALEDORT, LM
    DRUGS, 1993, 45 (04) : 541 - 547
  • [40] Currently available treatment options for anxiety disorders
    Baldwin, D.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 73 - 73